Related Experiment Videos
Endoscopic variceal ligation. Experience in 78 patients
1Department of Surgery, First Affiliated Hospital, Hunan Medical University, Changsha.
Chinese Medical Journal
|September 1, 1993
Summary
Endoscopic variceal ligation (EVL) effectively controls esophageal variceal bleeding. This safe and simple procedure offers an alternative to sclerotherapy, particularly for patients with severe liver issues or recurrent bleeding.
Area of Science:
- Gastroenterology
- Endoscopic procedures
- Hepatology
Background:
- Esophageal variceal hemorrhage is a serious complication of portal hypertension.
- Sclerotherapy has been the standard treatment, but carries risks.
- Endoscopic variceal ligation (EVL) emerged as a promising alternative.
Purpose of the Study:
- To evaluate the safety and efficacy of EVL in treating esophageal variceal hemorrhage.
- To assess EVL's effectiveness in controlling active bleeding and obliterating varices.
Main Methods:
- EVL was performed on 78 consecutive patients between May 1991 and July 1992.
- The procedure was used in 35 patients with active massive bleeding.
- Follow-up assessed bleeding control, varix obliteration, and complications.
Main Results:
- Initial EVL sessions controlled active bleeding in 31 out of 35 patients.
- Repeated EVL treatments led to complete varix obliteration in 32 patients.
- No ligation-related complications were observed during the study period.
Conclusions:
- EVL is a safe and effective method for treating esophageal varices.
- It is particularly beneficial for patients with poor liver function and recurrent bleeding.
- EVL presents a simpler alternative to sclerotherapy with no observed adverse effects.